Malonyl-CoA
Reactions involving Malonyl-CoA
Every recorded step where this molecule takes part
-
consumed FAS malonyl/acetyl transferase (MAT) domain Fatty Acid Synthesis (De Novo Lipogenesis) ST-0066
Malonyl-CoA + ACP → malonyl-ACP + CoA-SH
-
produced Acetyl-CoA carboxylase (ACC1) Fatty Acid Synthesis (De Novo Lipogenesis) ST-0064 rate-limiting
Acetyl-CoA + HCO3− + ATP → malonyl-CoA + ADP + Pi
Showing all 2 reactions.
Recent literature
Europe PMC · fetched just now · sorted by publication date
-
1
Advances and perspectives in genetically encoded biosensors for biomarker detection and theranostic circuits.
Xu J, Qi Q, Wang Q. · 2026-09-23
open access unreviewed -
2
Strategy for enhanced production of A40926B0 in <i>Nonomuraea gerenzanensis</i> using an efficient CRISPR/AsCas12f1 system.
Wang X, Zhai H, Gu D, Wang Y, Gao J, Du L, Zhuo L, Li X, Wang Y. · 2026-08-24
open access unreviewed -
3
Production improvement of dalbavancin precursor A40926B0 in <i>Nonomuraea gerenzanensis</i> through strain reconstruction and fermentation optimization.
Liu XY, Liu YQ, Zheng YL, Ruan JY, Fang P, Fang JL, Chen XA, Zhao QW, Lyu ZY, Li YQ. · 2026-08-03
open access unreviewed -
4
Engineering nonconventional yeasts to produce carboxylic acids: Advances and Prospects.
Zhang L, Fan Y, Shi W, Zhou X. · 2026-07-16
open access unreviewed -
5
Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights.
Xiao W, Tan D, Zeng W, Nie X, Wang M. · 2026-01-28
open access unreviewed -
6
Altered Acylcarnitine Metabolism in cardiac diseases: From molecular mechanisms to translational potential.
Wu J, Zhang Y, Liu J, Zhao W, Liu X, Dan J. · 2026-09-25
open access unreviewed -
7
Metabolic engineering of <i>Saccharomyces cerevisiae</i> for <i>de novo</i> biosynthesis of isoorientin.
Song Z, Zhang F, Qi X. · 2026-08-06
open access unreviewed -
8
The effect of ascorbic acid supplementation on plasma leptin and adiponectin levels: Systematic review of <i>in vivo</i> and <i>in vitro</i> studies.
Gholizadeh M, Noushzadeh Z, Movahed S, Aghapour B, Kolahi A, Mirmiran P. · 2026-07-04
open access unreviewed -
9
Targeting ROAM1 with UDP-GlcNAc nanosheets selective activates lysosomal AMPK to resolve metabolic dysfunction-associated steatotic liver disease.
Zhu J, Sun T, Wei F, Wang D, Liu F, Chen D, Liu X, Wang C, Deng S, Yang Y, Xiong Y, Xiang H, Li J, Li S, Ma W… · 2026-07-12
open access unreviewed -
10
Mitochondria-related pathogenic genes in acute and chronic kidney disease: a Mendelian randomization study.
Wang J, Yuan T, Wei Q, Xie K, Zhang J. · 2026-07-08
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.